NCT07289997
- Conditions
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma, AFPGC, Immunotherapy, +1 more
- Locations
-
- Hebei Medical University Fourth Hospital Shijiazhuang, Hebei, China
Clinical trial condition
AFP Gastric or Gastroesophageal Junction Adenocarcinoma
Explore clinical trials studying AFP Gastric or Gastroesophageal Junction Adenocarcinoma. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
AFP Gastric or Gastroesophageal Junction Adenocarcinoma trial results
Not Yet Recruiting
Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma
NCT07515625
- Conditions
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
Not specified
Not Yet Recruiting
Sintilimab Plus Apatinib and SOX as First-line Treatment in Patients With AFP Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06973330
- Conditions
- AFP Gastric or Gastroesophageal Junction Adenocarcinoma
- Locations
-
Not specified